Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 17 Mar 2023
Bladder cancer is not a rare disease. It is one of the 10 most common cancers in the UK and the 5th most common cancer in the European Union.
Read Full NewsQ&A: Discussing 2027 GOLD Report Updates in COPD, With David Singh, MD
The HCPFive: Top News for Healthcare Providers from the Week of 11/1
Catch up on any of the neurology headlines you may have missed in October 2026, compiled into 1 place by the NeurologyLive® team.
Interim phase 1b data showed cizutamig produced rapid, sustained improvement in generalized myasthenia gravis with no cases of cytokine release syndrome.
SHASTA-3/4: Plozasiran Could Cut Acute Pancreatitis Risk by 78% Across sHTG Spectrum
Bimekizumab Ranks First in HS Network Meta-Analysis of 17 Trials
Unmet Needs in HS and Emerging Oral Options, With Martina Porter, MD
1.
From 40 to 74, the US Preventive Services Task Force advises every two years for screening mammography.
2.
To refute accusations that it failed to issue a cancer warning, Roundup's maker is asking lawmakers for assistance.
3.
ASTRO Guideline Addresses Specifics of HPV-Associated Oropharyngeal Cancer
4.
Insurance Claim Denials for Preventive Care More Common in At-Risk Patients
5.
Research finds low uptake of supportive care at the end-of-life for patients with advanced cancer
1.
Unmasking the Hidden Symptoms of Ovarian Cancer
2.
Developmental Regulation of Pediatric Red-Cell Production
3.
Beyond the Organs: Navigating the Era of Tissue-Agnostic Therapies in Modern Cancer Management
4.
Liquid Biopsy: A Revolutionary Tool for Early Detection and Monitoring of Colorectal Cancer
5.
Tumor Ecosystem Modulation in Precision Oncology
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VI
2.
Role of Nimotuzumab in Management of Nasopharyngeal Cancer
3.
Navigating the Complexities of Ph Negative ALL - Part X
4.
Newer Immunotherapies for Myeloma- A Comprehensive Overview
5.
A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge